Clinical Trial Update: A Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole, Carbamazepine, Quinidine and Fluconazole on the Pharmacokinetics and Safety of EDP-323. [Phase 1]

View source ↗

Summary

This Phase 1 drug-drug interaction study evaluated how itraconazole, carbamazepine, quinidine, and fluconazole affect the pharmacokinetics and safety of the inv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• Carbamazepine (Carbamazepine)
• EDP-323 (EDP-323)
• Fluconazole (Fluconazole)
• Itraconazole (Itraconazole)
• Quinidine (quinidine)

Snippet

Sponsor: Enanta Pharmaceuticals, Inc | Conditions: RSV Infection, Drug Drug Interaction (DDI) | Phase 1 | Status: COMPLETED